HomePBDA • FRA
add
Protalix Biotherapeutics Inc
Nakaraang pagsara
€1.46
Sakop ng araw
€1.46 - €1.51
Sakop ng taon
€0.64 - €2.70
Market cap
132.94M USD
Average na Volume
322.00
P/E ratio
-
Dividend yield
-
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 10.11M | 169.82% |
Gastos sa pagpapatakbo | 6.08M | 1.27% |
Net na kita | -3.62M | 21.24% |
Net profit margin | -35.79 | 70.81% |
Kita sa bawat share | — | — |
EBITDA | -3.80M | 16.21% |
Aktuwal na % ng binabayarang buwis | 3.03% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 34.74M | -28.35% |
Kabuuang asset | 73.89M | -17.74% |
Kabuuang sagutin | 28.68M | -52.22% |
Kabuuang equity | 45.21M | — |
Natitirang share | 79.61M | — |
Presyo para makapag-book | 2.52 | — |
Return on assets | -14.07% | — |
Return on capital | -20.90% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -3.62M | 21.24% |
Cash mula sa mga operasyon | -5.06M | -220.77% |
Cash mula sa pag-invest | -312.00K | 48.51% |
Cash mula sa financing | 5.08M | — |
Net change in cash | -302.00K | -108.45% |
Malayang cash flow | -3.76M | -175.74% |
Tungkol
Protalix BioTherapeutics is an Israeli pharmaceutical company that manufactures a plant-based enzyme, taliglucerase alfa, which has received U.S. Food and Drug Administration approval for the treatment of Gaucher disease. Wikipedia
CEO
Itinatag
1993
Headquarters
Website
Mga Empleyado
213
